biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > My New Post

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton May 06, 2021 4:50pm

135 Views

Post# 33145818

RE:RE:My New Post

I'm with you, fuzzy. I could make untold millions if I could go back. I would have flipped it every time Haywood did, which was 3 or 4 times a year. And when a CEO indicated 3 deals by Christmas '16, I'd have sold and put it with the bookies on Trump. Who'd o' thought?

But it doesn't count, does it? Hindsight, it's worse than dreaming. Dreaming is fantasy. Hindsight is certain.

Good post, fuzzy.

jd

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs